Berlin: Bayer has received approval from the Center for Drug Evaluation (CDE) of China's National Medical Products ...

Matthew Starr, MD, highlights the RHONE-X trial's findings on faricimab, showcasing improved vision and reduced treatment ...

New research links diffuse-trickling patterns in fundus autofluorescence to increased ellipsoidal zone loss, highlighting ...

Porton Advanced, a leading contract development and manufacturing organization (CDMO) specializing in advanced therapy ...

The ophthalmic diagnostic equipment market plays a vital role in modern eye care, supporting the diagnosis and management of various vision-related disorders. These devices enable ophthalmologists and ...

OpenAI's doomsday bunker plan, the "potential benefits" of propaganda bots, plus the best fake books you can't read this ...

Wakle Forest University School of Medicine said its Eye Institute represents a $100 million capital investment. The current projection is debuting in spring 2026.

The US FDA has cleared Grifols' investigational new drug (IND) application to commence a Phase II trial of GRF312 Ophthalmic ...